#JPM2026 Day Two Update
Stay ahead with Biomedtracker’s comprehensive coverage of Day 2 at the 44th Annual J.P. Morgan Healthcare Conference. This update delivers key takeaways from presentations by leading pharma, biotech, and medtech companies, providing the context and commercial implications you need to make informed decisions.
What’s Inside
- Mega Cap Movers: Strategic updates from AstraZeneca, Novo Nordisk, and Thermo Fisher Scientific, including pipeline milestones and growth targets.
- Large Cap Highlights: Bayer’s blockbuster ambitions, Alcon’s surgical ecosystem evolution, and GSK’s transformative respiratory and oncology programs.
- Mid and Small Cap Innovation: Breakthroughs in oncology, rare diseases, and precision medicine from BeOne Medicines, Cogent Biosciences, Crinetics, and more.
- Market Trends: Competitive dynamics in obesity, immunology, and gene therapy shaping 2026 and beyond.
Get the complete analysis of Day 2 presentations, including detailed company profiles, pipeline updates, and commercial outlooks.
